PASCARELLA, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 1.239
AS - Asia 1.236
EU - Europa 750
SA - Sud America 275
AF - Africa 29
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.535
Nazione #
US - Stati Uniti d'America 1.170
SG - Singapore 556
IT - Italia 336
CN - Cina 242
BR - Brasile 213
VN - Vietnam 166
IN - India 108
EE - Estonia 101
DE - Germania 97
HK - Hong Kong 58
FI - Finlandia 39
CA - Canada 35
GB - Regno Unito 35
NL - Olanda 34
BD - Bangladesh 29
AR - Argentina 27
MX - Messico 19
ID - Indonesia 14
FR - Francia 13
AT - Austria 12
ES - Italia 12
RU - Federazione Russa 12
CO - Colombia 11
SE - Svezia 11
JP - Giappone 10
IQ - Iraq 9
PL - Polonia 9
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
MA - Marocco 7
EC - Ecuador 6
PE - Perù 6
TR - Turchia 6
CH - Svizzera 5
EG - Egitto 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
UA - Ucraina 4
VE - Venezuela 4
AU - Australia 3
GR - Grecia 3
KZ - Kazakistan 3
LV - Lettonia 3
UZ - Uzbekistan 3
BE - Belgio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
Totale 3.535
Città #
San Jose 318
Singapore 266
Ashburn 168
Dallas 137
Santa Clara 87
Munich 75
Bengaluru 72
Hefei 66
Hong Kong 58
Ho Chi Minh City 56
Beijing 54
Los Angeles 40
Milan 37
Boardman 34
Hanoi 32
Chicago 22
Rome 22
Turku 22
Chandler 18
Helsinki 17
New York 17
London 15
Chennai 13
Amsterdam 12
Genoa 12
Rio de Janeiro 12
São Paulo 11
Orem 10
West Jordan 10
Boston 9
Montreal 9
Ninh Bình 9
Seattle 9
Tokyo 9
Haiphong 8
Warsaw 8
Gioia Tauro 7
Hải Dương 7
Atlanta 6
Bogotá 6
Brasília 6
Brooklyn 6
Da Nang 6
Mexico City 6
Olomouc 6
San Francisco 6
San Nicola Manfredi 6
Taranto 6
Thái Bình 6
Toronto 6
Tremestieri Etneo 6
Bari 5
Belo Horizonte 5
Cosenza 5
Lawrence 5
Manchester 5
Misterbianco 5
Naples 5
Princeton 5
The Dalles 5
Vienna 5
Yiwu 5
Assago 4
Aversa 4
Bergamo 4
Biên Hòa 4
Casalecchio di Reno 4
Curitiba 4
Dublin 4
New Delhi 4
Palermo 4
Suzano 4
Washington 4
Zhengzhou 4
Betim 3
Buffalo 3
Busto Arsizio 3
Bắc Giang 3
Bắc Ninh 3
Campinas 3
Carney 3
Charlotte 3
Cittanova 3
Columbus 3
Council Bluffs 3
Denver 3
Ercolano 3
Florence 3
Fort Worth 3
Istanbul 3
Manaus 3
Medellín 3
Mesa 3
Miami 3
Mission 3
Nuremberg 3
Padova 3
Phoenix 3
Piscataway 3
Pizzighettone 3
Totale 2.047
Nome #
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 143
Vacuolated PAS‐positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy 126
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 94
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 92
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 81
Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature 80
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 76
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 75
Status epilepticus in pregnancy: a literature review and a protocol proposal 73
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 66
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 64
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 62
Investigating Peri-Ictal MRI Abnormalities: A Prospective Neuroimaging Study on Status Epilepticus, Seizure Clusters, and Single Seizures 62
Therapeutic approach to neurological manifestations of Angelman syndrome 61
Provocative techniques for functional/dissociative seizure: the colored pad test – a safe and reliable procedure 61
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance 61
When the practice does not meet the evidence: An Italian survey on the use of antiseizure medications in routine neurosurgery practice 59
The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case-control study 57
Functional seizures and binge eating disorder: A cross-sectional study 56
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 56
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis 56
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 55
Investigation into the casual or causal association of cerebral venous thrombosis and myelin oligodendrocyte glycoprotein antibody‑associated disease: A case report and literature review 55
Peculiar CADASIL phenotype in monozygotic twins carrying a novel NOTCH3 pathogenetic variant 54
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 53
Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families 51
Alien hand syndrome-like functional seizures in a patient with right temporo-parietal damage and neurocognitive disorder: a case report 51
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study 50
Seizures When Exiting a Bath: A Rare Type of Reflex Epilepsy 50
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 50
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks? 50
Brainstem Posterior Reversible Encephalopathy Syndrome in an Asymptomatic Patient. 49
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 49
Second-Line Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy 48
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 48
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 48
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 48
Do Medical Complications Impact Long-Term Outcomes in Prolonged Disorders of Consciousness? 47
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 46
The relevance of MRI blood-sensitive sequences in the diagnostic assessment of late-onset epilepsy 45
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 45
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis 45
Epilepsy in Cerebrovascular Diseases: A Narrative Review 43
De novo myoclonic status epilepticus in Alzheimer disease 42
Convolutional Neural Network Classification of Rest EEG Signals among People with Epilepsy, Psychogenic Non Epileptic Seizures and Control Subjects 41
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 41
Human expressive movements: The boundary between health and disease from a contaminated perspective 40
Anti-seizure medications in patients with renal failure undergoing dialysis: how to manage? 39
Severe hypomagnesemia mimicking acute stroke: a rare but overlooked mimic? 38
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 38
Modern neurophysiological techniques indexing normal or abnormal brain aging 35
Multi-center observational study on occurrence and related clinical factors of neurogenic heterotopic ossification in patients with disorders of consciousness 34
Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary data 34
null 33
Long-term outcome of patients with disorders of consciousness with and without epileptiform activity and seizures: a prospective single centre cohort study 33
Instrumentation for TMS-EEG Experiment: ArTGen and a Custom EEG Interface 33
Repeated transcranial direct current stimulation in prolonged disorders of consciousness: A double-blind cross-over study 32
HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine? 32
Late-onset diplopia: an unusual presentation of posterior cortical atrophy 32
Late-onset Fabry disease due to a new (p.Pro380Leu) pathogenic variant of GLA Gene 32
Correction to: A video of best practice recommendations for making botulinum toxin therapy safe during the COVID?19 pandemic (Neurological Sciences, (2021), 42, 9, (3937-3938), 10.1007/s10072-021-05375-z) 31
Evidence of small fiber neuropathy in a patient with Ehlers–Danlos syndrome, hypermobility-type 31
The neurological core features of the infantile-onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian family 30
Hemiparkinsonism-hemiatrophy syndrome: a long-term clinical, neurophysiological, and neuroimaging follow-up study 29
Myoclonus: Differential diagnosis and current management 29
Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients 29
Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study 29
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 28
Palatal tremor in a patient with prolonged vegetative state after ischemic stroke 27
Clinical and electroencephalographic on–off effect of amantadine in chronic non-traumatic minimally conscious state 25
Epilepsy and migraine: a diagnostic and therapeutic challenge 24
Neurological Causes of Dizziness and Vertigo 23
Urinary Liver-Type Fatty Acid Binding Protein as a Postoperative Marker of Acute Kidney Injury in Patients Undergoing EndovascularAortic Aneurysm Repair 23
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 20
An EEG-Based Edge-AI Framework for Alzheimer's and Creutzfeldt-Jakob Disease Classification 4
B-cell–driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review 3
Effective Surgical Management of Coexisting DNET-Related Focal Epilepsy and Epilepsy with Eyelid Myoclonia 2
Dietary Modulation of Migraine: Metabolic, Neuroinflammatory and Microbiota-Mediated Mechanisms 1
Epilepsia partialis continua as the presenting manifestation of Creutzfeldt–Jakob disease: A video-polygraphic clinical vignette 1
Seizure and Status Epilepticus in Human Organophosphate Poisoning: A Narrative Review 1
Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centers 1
Totale 3.641
Categoria #
all - tutte 22.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 1 0 5 4 0 0 1 2 1 2 0
2022/202379 10 0 6 6 11 6 1 5 11 14 5 4
2023/2024167 17 15 6 5 5 10 24 17 16 14 11 27
2024/2025999 97 74 39 47 32 126 43 18 72 109 117 225
2025/20262.361 135 198 267 358 236 108 269 130 288 210 151 11
Totale 3.641